+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunohematology Tests - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 69 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5505025
The publisher's Medical Devices sector report, “Immunohematology Tests - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Immunohematology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunohematology Tests includes studies of antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. This category includes blood typing reagents and antibody detection reagents.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunohematology Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunohematology Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunohematology Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Immunohematology Tests Overview
3 Products under Development
3.1 Immunohematology Tests - Pipeline Products by Stage of Development
3.2 Immunohematology Tests - Pipeline Products by Segment
3.3 Immunohematology Tests - Pipeline Products by Territory
3.4 Immunohematology Tests - Pipeline Products by Regulatory Path
3.5 Immunohematology Tests - Pipeline Products by Estimated Approval Date
4 Immunohematology Tests - Pipeline Products under Development by Companies
4.1 Immunohematology Companies - Pipeline Products by Stage of Development
4.2 Immunohematology Tests - Pipeline Products by Stage of Development
5 Immunohematology Companies and Product Overview
5.1 AbSorber AB Company Overview
5.1.1 AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
5.2 Alba Bioscience Limited Company Overview
5.2.1 Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
5.3 Amity University Company Overview
5.3.1 Amity University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biofortuna Ltd Company Overview
5.4.1 Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Calviri Inc Company Overview
5.5.1 Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Grifols SA Company Overview
5.6.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
5.7 Ortho Clinical Diagnostics Holdings Plc Company Overview
5.7.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Quotient Ltd Company Overview
5.8.1 Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 SiDx Inc Company Overview
5.9.1 SiDx Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Transfusion & Transplantation Technologies (Inactive) Company Overview
5.10.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6 Immunohematology- Recent Developments
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer
List of Tables
Immunohematology Tests - Pipeline Products by Stage of Development
Immunohematology Tests - Pipeline Products by Segment
Immunohematology Tests - Pipeline Products by Territory
Immunohematology Tests - Pipeline Products by Regulatory Path
Immunohematology Tests - Pipeline Products by Estimated Approval Date
Immunohematology Companies - Pipeline Products by Stage of Development
Immunohematology Tests - Pipeline Products by Stage of Development
Glossary
List of Figures
Immunohematology Tests - Pipeline Products by Stage of Development
Immunohematology Tests - Pipeline Products by Segment
Immunohematology Tests - Pipeline Products by Territory
Immunohematology Tests - Pipeline Products by Regulatory Path

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbSorber AB
  • Alba Bioscience Limited
  • Amity University
  • Biofortuna Ltd
  • Calviri Inc
  • Grifols SA
  • Ortho Clinical Diagnostics Holdings Plc
  • Quotient Ltd
  • SiDx Inc
  • Transfusion & Transplantation Technologies (Inactive)